Shelter Pharma Ltd
₹ 41.2
-3.28%
11 Jun
- close price
About
Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including
food supplements for animals[1]
Key Points
- Market Cap ₹ 47.7 Cr.
- Current Price ₹ 41.2
- High / Low ₹ 69.7 / 35.7
- Stock P/E 6.59
- Book Value ₹ 37.0
- Dividend Yield 0.80 %
- ROCE 24.5 %
- ROE 18.4 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.12 times its book value
- Company has delivered good profit growth of 146% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.6%
Cons
- Promoter holding has decreased over last quarter: -2.65%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 28.09 | 29.95 | 30.07 | 22.48 | 30.06 | 36.15 | 39.93 | 50.66 | |
| 27.94 | 30.65 | 29.83 | 22.29 | 27.01 | 28.00 | 31.02 | 40.59 | |
| Operating Profit | 0.15 | -0.70 | 0.24 | 0.19 | 3.05 | 8.15 | 8.91 | 10.07 |
| OPM % | 0.53% | -2.34% | 0.80% | 0.85% | 10.15% | 22.54% | 22.31% | 19.88% |
| 0.00 | 0.83 | 0.01 | 0.01 | 0.00 | -0.97 | -0.12 | 0.01 | |
| Interest | 0.00 | 0.00 | 0.01 | 0.02 | 0.08 | 0.03 | 0.26 | 0.13 |
| Depreciation | 0.10 | 0.07 | 0.13 | 0.12 | 0.17 | 0.16 | 0.25 | 0.27 |
| Profit before tax | 0.05 | 0.06 | 0.11 | 0.06 | 2.80 | 6.99 | 8.28 | 9.68 |
| Tax % | 20.00% | 16.67% | 27.27% | 33.33% | 26.79% | 25.46% | 25.12% | 25.21% |
| 0.05 | 0.05 | 0.08 | 0.04 | 2.06 | 5.21 | 6.20 | 7.24 | |
| EPS in Rs | 1.10 | 1.10 | 1.76 | 0.83 | 42.56 | 6.73 | 5.36 | 6.26 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 19% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 146% |
| 3 Years: | 52% |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 24% |
| 3 Years: | 26% |
| Last Year: | 18% |
Balance Sheet
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.45 | 0.45 | 0.45 | 0.48 | 0.48 | 7.74 | 11.56 | 11.56 |
| Reserves | 7.31 | 7.32 | 6.53 | 6.63 | 8.32 | 6.81 | 24.26 | 31.16 |
| 2.07 | 0.11 | 0.24 | 0.00 | 0.13 | 1.78 | 0.57 | 1.04 | |
| 1.73 | 3.76 | 3.41 | 3.09 | 3.91 | 5.12 | 1.52 | 4.58 | |
| Total Liabilities | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 48.34 |
| 2.61 | 2.71 | 1.77 | 1.57 | 1.45 | 2.52 | 4.26 | 5.96 | |
| CWIP | 0.14 | 0.11 | 0.00 | 0.00 | 0.55 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.68 | 0.68 | 0.68 | 0.00 | 0.00 | 0.68 |
| 8.81 | 8.82 | 8.18 | 7.95 | 10.16 | 18.93 | 33.65 | 41.70 | |
| Total Assets | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 48.34 |
Cash Flows
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | -0.27 | -0.28 | 0.52 | 0.00 | -1.85 | 5.48 | ||
| 0.00 | 0.29 | 0.03 | -0.85 | 0.11 | -4.54 | -7.13 | ||
| 0.00 | 0.00 | 0.48 | 0.06 | 0.21 | 11.01 | 0.03 | ||
| Net Cash Flow | 0.00 | 0.02 | 0.23 | -0.27 | 0.33 | 4.61 | -1.62 |
Ratios
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 12.99 | 14.14 | 7.40 | 12.34 | 19.55 | 82.69 | 80.90 | 68.23 |
| Inventory Days | 61.39 | 49.67 | 55.59 | 69.41 | 80.06 | 110.68 | 125.33 | 127.15 |
| Days Payable | 2.49 | 2.16 | 3.35 | 5.35 | 4.52 | 6.54 | 8.96 | 12.32 |
| Cash Conversion Cycle | 71.89 | 61.65 | 59.64 | 76.40 | 95.09 | 186.84 | 197.26 | 183.06 |
| Working Capital Days | 91.35 | 59.59 | 57.05 | 74.85 | 72.49 | 134.69 | 212.07 | 182.57 |
| ROCE % | 0.68% | 1.12% | 35.91% | 63.26% | 32.85% | 24.48% |
Documents
Announcements
-
Non-Applicability Of Regulation 23(9) As Per Regulation 15 Of Chapter IV Of SEBI (LODR) Regulations, 2015 For The Half Year And Year Ended March 2025.
29 May - Shelter Pharma certifies non-applicability of related party transaction reporting for FY 2025 as SME listed company.
-
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Appointment Of CA Ismail Ibrahimbhai Lakhani (M/S. I I LAKHANI & CO), FRN NO: 143750W Chartered Accountants As Internal Auditor
29 May - Appointment of CA Ismail Ibrahimbhai Lakhani as internal auditor for FY 2025-26.
-
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Reappointment Of M/S. Murtuza Mandorwala & Associates As Secretarial Auditor For The Period Of 5 Years
29 May - Reappointment of secretarial auditor M/s. Murtuza Mandorwala & Associates for five years from 2025-26 to 2029-30.
-
Submission Of The Audited Standalone Financial Results For The Half Year And Year Ended March 31, 2025
29 May - Shelter Pharma reports FY25 audited results with Rs 967.7L profit; appoints internal and secretarial auditors.
-
Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Audited Standalone Financial Results For The Half Year And Year Ended March 31, 2025
29 May - Audited FY25 standalone results approved; internal and secretarial auditors appointed for FY26 onwards.
Business Overview:[1]
SPL is a GMP & HACCP certified and ISO 9001:2015 certified manufacturer and seller of a range of herbal Ayurvedic medicines in India for humans and food supplements for animals